PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 3 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 7.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $195,821 | +39.3% | 200,000 | 0.0% | 0.10% | +32.0% |
| Q1 2023 | $140,574 | +80228.0% | 200,000 | 0.0% | 0.08% | -23.5% |
| Q4 2022 | $175 | -99.9% | 200,000 | 0.0% | 0.10% | -6.7% |
| Q3 2022 | $178,000 | +4.7% | 200,000 | 0.0% | 0.10% | +8.2% |
| Q2 2022 | $170,000 | -4.0% | 200,000 | 0.0% | 0.10% | +11.5% |
| Q1 2022 | $177,000 | -3.3% | 200,000 | 0.0% | 0.09% | -1.1% |
| Q4 2021 | $183,000 | +5.2% | 200,000 | 0.0% | 0.09% | -4.3% |
| Q3 2021 | $174,000 | – | 200,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cohanzick Management, LLC | 25,112,000 | $25,557,982 | 22.10% |
| Westchester Capital Management, LLC | 8,267,000 | $8,308,536 | 0.24% |
| MACQUARIE GROUP LTD | 5,359,000 | $5,386,000 | 0.01% |